Chemical icons Olin and Huntsman to merge
1 min read
The story
Olin (OLN, ~$6.8B revenue) and Huntsman (HUN, ~$5.7B revenue) have announced a merger, creating a combined chemicals entity with over $12B in top-line scale. Both companies are currently unprofitable at the net level — OLN at -1.5% net margin and HUN at -4.0% — suggesting the deal is driven by synergy capture, overhead consolidation, and potentially improved pricing power in overlapping chemical markets rather than near-term earnings strength.
The key question is which company's shareholders receive the better deal and whether synergies are real enough to move the needle on profitability. With both stocks carrying negative EPS, the market will scrutinize deal terms, exchange ratios, and management's synergy guidance carefully. Watch for arbitrage spread behavior, any regulatory antitrust review flags, and early analyst reactions to deal structure as the primary near-term price drivers.
The case — both sides
A combined entity with $12.5B in revenues and overlapping chemical manufacturing infrastructure could generate meaningful fixed-cost synergies, potentially flipping both companies' negative net margins into profitability and triggering a re-rating from depressed current multiples.
Both OLN and HUN are already reporting net losses with declining revenues, meaning the merger combines two operationally challenged businesses — if synergies disappoint or integration costs are high, deal dilution could pressure shares of both companies further.
The house read
Two-sidedWith OLN and HUN both running net losses, the question is whether the merger's synergy case is credible enough to re-rate either stock, or whether the deal merely combines two struggling balance sheets.
Wrong ifIf deal terms show a heavy stock-for-stock exchange unfavorable to one side, or if regulators signal antitrust scrutiny in chlor-alkali or MDI markets, the spread collapses and both names could re-price lower together.
Published read · research, not advice